Back to Search
LOUIS ALEDORT, MD
MD
Medical Oncology Physician
NPI: 1861424061Individual
Specialties, Licenses & Credentials
Hematology (Internal Medicine) Physician
Internal Medicine — Hematology
Code: 207RH0000X
090221(NY)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
090221(NY)
Research & Publications (20)
Mild and moderate factor VIII deficiency: inhibitor risks.
PMID 19548903·J Thromb Haemost·2009
8-other
Factor VIII inhibitor bypassing activity (FEIBA) - addressing safety issues.
PMID 17961169·Haemophilia·2008
6-review
United States' factor XI-deficiency patients need a safer treatment.
PMID 16315257·Am J Hematol·2005
8-other
Platelet bleeding disorders and approach to their management.
PMID 15720955·Curr Hematol Rep·2005
8-other
Do we need a better test? Can thrombin generation be useful?
PMID 14965481·Curr Hematol Rep·2004
8-other
Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity.
PMID 15456478·J Thromb Haemost·2004
4-observational
Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies.
PMID 15224353·Am J Hematol·2004
8-other
Is the incidence and prevalence of inhibitors greater with recombinant products? Yes.
PMID 15140115·J Thromb Haemost·2004
7-preclinical
Why thrombin generation? From bench to bedside.
PMID 12853706·Pathophysiol Haemost Thromb·2003
8-other
Can costs of hemophilia products be curtailed? Not as we do business today!
PMID 12362221·Thromb Haemost·2002
8-other
The role of porcine factor VIII in the management of unexpected bleeding episodes.
PMID 11882078·Haemophilia·2002
5-case
Making a therapeutic choice: human versus recombinant fractions - can we do it?
PMID 11240611·Haemophilia·2001
8-other
Unexpected bleeding disorders: identification, diagnosis and management.
PMID 11203269·Haemophilia·2000
8-other
Factor VIII inhibitors. Immune tolerance induction: is it cost effective? We know too little.
PMID 10919412·Semin Thromb Hemost·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1190 5TH AVENUE GUGGENHEIM PAVILL, MOUNT SINAI HOSPITAL RUTTENBERG TREATMENT CENTER
NEW YORK, NY 10029 - Phone
- (212) 241-6756
Quick Facts
- NPI
- 1861424061
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile